Reports

• Report: Roundtable Stakeholder Consultation on Section 2.21 (Risk/Safety Information Communication) of the Consumer Advertising Guidelines for Marketed Health Products (for nonprescription drugs including natural health products)
  
  
  • Invitational Roundtable - Risk Information Communication (Section 2.21) of the Revised Draft Consumer Advertising Guidelines for Marketed Health Products
    
    
    • Issue Paper - Health Canada's Approach to the Inclusion of Risk / Safety Information Communication (Section 2.21) in the Revised Consumer Advertising Guidelines for Marketed Health Products (For Nonprescription Drugs Including Natural Health Products)
      
      
  • Second Consultation Draft - Consumer Advertising Guidelines for Marketed Health Products (For Nonprescription Drugs including Natural Health Products)
    
    
  • Consultation Draft - Consumer Advertising Guidelines for Marketed Health Products (For Nonprescription Drugs including Natural Health Products)